Loading data
BRLSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 31.48 m USD | 29.1 m USD | 31.38 m USD | — | — |
| Cost of revenue | 26.57 m USD | 25.48 m USD | 31.29 m USD | — | — |
| Gross profit | 3.51 m USD | 2.19 m USD | -1.3 m USD | 175.95 m USD | 172.5 m USD |
| Research and development expense | 202 k USD | 197 k USD | 460 k USD | — | — |
| Selling, general and administrative expense | 14.55 m USD | 22.59 m USD | 18.65 m USD | — | — |
| Operating profit | -11.04 m USD | -20.4 m USD | -19.95 m USD | -2.89 m USD | — |
| Interest expense | 5.99 m USD | 5.06 m USD | — | — | — |
| Profit before tax | -19.05 m USD | -25.46 m USD | — | — | — |
| Income tax expense | -66.71 k USD | -134.9 k USD | -336.03 k USD | — | — |
| Net income (reported basis) | -18.98 m USD | -25.33 m USD | -27.48 m USD | -302.54 k USD | — |
| Net income attributable to common shareholders | -18.98 m USD | -25.33 m USD | — | — | — |
| Basic earnings per share | -0.89 USD/share | -1.25 USD/share | -2.56 USD/share | — | — |
| Diluted earnings per share | -0.89 USD/share | -1.25 USD/share | -2.56 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.